Company
Management team:
Chief Executive Officer: Prof CHAN Chi Wai Michael
Chief Operating Officer: Prof POON Lit Man Leo
Senior Advisor: Prof PEIRIS Joseph Sriyal Malik
R&D team:
Chief Scientific Officer: Prof HUI Pui Yan Kenrie
Chief Technical Officer: Dr CHING Hiu Ha Rachel
R&D executive: Dr LI Tak Ho Alex
Technical Officer: Miss HO Wing Chi Taylor
Honorary Pathologist: Prof NICHOLLS John Malcolm
Honorary Business Development Advisor: Dr HO Chi Yung Alfred
Clinical and Overseas Advisors:
Prof TAM KH Paul KH - Vice President, Macau University of Science and Technology
Prof HO CM James - Clinical Associate Professor, at the Department of Medicine, School of Clinical Medicine, HKU
Prof LAU Yu-lung - Chair Professor, Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine
Prof MATTHAY Michael - Professor, School of Medicine University of California
Prof KIM F Carla - Professor, Harvard Medical School, Harvard University
Description
Respiratory diseases, including Acute Lung Injury, Acute Respiratory Distress Syndrome, and chronic conditions like Asthma and Chronic Obstructive Pulmonary Disease, present significant global health challenges. These conditions, exacerbated by viral infections such as H5N1, SARS, MERS, and SARS-CoV-2, lead to high morbidity and mortality rates, severely impacting quality of life and straining healthcare systems.
C2iTech Limited, a spin-off from a prestigious academic institution, is dedicated to transforming respiratory health through innovative technologies. We specialise in personalised organoid cultivation and offer a comprehensive range of services, including organoid cryopreservation, novel respiratory drug screening, and extensive respiratory virus research. Our unique organoid platform enables the standardisation and development of tailored culture media and frozen organoid products.
Our mission is to revolutionize healthcare by addressing unmet medical needs with cutting-edge solutions. By leveraging our scientific expertise and advanced technologies, we aim to improve patient outcomes and enhance the effectiveness of respiratory health interventions.